January 16, 2019
Via: Mass DeviceAbbott (NYSE:ABT) said today that it plans to acquire mitral heart valve replacement tech developer Cephea Valve Technologies for an undisclosed amount. The Chicago-area healthcare giant backed the Santa Clara, Calif.-based valve company in July 2015 and secured an option […]
September 26, 2023
September 21, 2023
September 19, 2023
September 14, 2023
September 12, 2023
September 25, 2023
September 19, 2023
September 25, 2023
September 21, 2023